Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04119063 · ClinicalTrials.gov registry record · Early Phase 1

Evaluating Wearable Robotic Assistance on Gait

A Early Phase 1 study of Cerebral Palsy, sponsored by Northern Arizona University.

Completed
Registry status
Early Phase 1
Development phase
6
Enrollment target
1
Study location

NCT04119063: Completed Early Phase 1 study of Cerebral Palsy, sponsored by Northern Arizona University.

NCT04119063 is a Early Phase 1 study of Cerebral Palsy that has completed, run by Northern Arizona University. The registered enrollment target is 6 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04119063, a Early Phase 1 study of Cerebral Palsy, has completed, sponsored by Northern Arizona University.

COMPLETED
Registry status
Early Phase 1
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The overarching goal of this study is to improve mobility in individuals with movement disorders through advances in wearable assistance (i.e. powered orthoses).

Primary Outcome

The change in the metabolic energy required to walk will be measured using a portable metabolic measurement system (Cosmed K5). Units: change in % difference post vs pre gait training.

Conditions Studied

Interventions

  • DEVICE powered orthosis

Study Locations (1)

Arizona

  • Northern Arizona University - Flagstaff

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2019-09-08
Est. Completion 2022-11-20
Phase Early Phase 1
Northern Arizona University

23 total trials

What the finished NCT04119063 record still lists

NCT04119063 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which powered orthosis is the first listed.

NCT04119063 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT04119063 about?

NCT04119063 is a clinical study titled "Evaluating Wearable Robotic Assistance on Gait". The overarching goal of this study is to improve mobility in individuals with movement disorders through advances in wearable assistance (i.e. powered orthoses).

What is the current status of trial NCT04119063?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2019-09-08. Estimated completion is 2022-11-20.

What conditions does trial NCT04119063 study?

This clinical trial studies the following conditions: Cerebral Palsy.

What interventions are being tested in trial NCT04119063?

The interventions under investigation include: powered orthosis (DEVICE).

Who is sponsoring clinical trial NCT04119063?

This trial is sponsored by Northern Arizona University, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04119063 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04119063's enrollment target sits among peer trials

6 86th of 91 higher than 6 of 91 other Cerebral Palsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04119063, the US trial registry maintained by the National Library of Medicine. NCT04119063 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.